Abstract We present a novel strategy based on dataindependent acquisition coupled to targeted data extraction for the detection and identification of site-specific modifications of targeted peptides in a completely unbiased manner. This method requires prior knowledge of the site of the modification along the peptide backbone from the protein of interest, but not the mass of the modification. The procedure, named multiplex adduct peptide profiling (MAPP), consists of three steps: 1) A fragment-ion tag is extracted from the data, consisting of the b-type and y-type ion series from the N and C-terminus, respectively, up to the amino-acid position that is believed to be modified; 2) MS1 features are matched to the fragment-ion tag in retention-time space, using the isolation window as a pre-filter to enable calculation of the mass of the modification; and 3) modified fragment ions are overlaid with the unmodified fragment ions to verify the mass calculated in step 2. We discuss the development, applications, and limitations of this new method for detection of unknown peptide modifications. We present an application of the method in profiling adducted peptides derived from abundant proteins in biological fluids with the ultimate objective of detecting biomarkers of exposure to reactive species.
Introduction
Technological advances in instrumentation [1] [2] [3] , sample preparation [4] [5] [6] [7] , and bioinformatics [8] [9] [10] [11] [12] [13] have made LC-MS-MS the premiere analytical method for global proteomics, with the identification of several thousands of proteins in a single injection analysis being routine [2] . However, protein identification and quantification only provides a limited view of the altered biological pathways and networks that contribute to complex human diseases including cancer. Almost all proteins are modified post-translationally by a diverse set (n>200) of molecules. Protein modifications can be either enzymatically driven or a result of chemical (i.e., non-enzymatic) modifications, often caused by reactive electrophiles created from the metabolism of exogenous compounds or a result of by-products of endogenous biological processes (e.g. reactive oxygen and/or nitrogen species) [14, 15] . The former diversifies protein function, whereas the latter may lead to altered or inhibited function and thus is often referred to as protein damage [16, 17] . Damaged proteins can have adverse biological effects and have been implicated in a variety of agerelated diseases (e.g. neurological disorders, atherosclerosis, and diabetes mellitus) [18] .
As a result, a more thorough understanding of the biological processes mediated and/or affected by both enzymatic and chemical modifications of proteins in relation to disease is imperative. However, detection of protein modifications by LC-MS-MS has been limited. These techniques are often are focused on the presence and/or abundance of a single enzymatic or chemical protein modification [19] . Detection of modified proteins presents several analytical challenges, including:
1. Modified proteins are often present at sub-stoichiometric levels, making enrichment strategies necessary; 2. For bottom-up proteomic strategies, detection of a modified protein is dependent on having a proteotypic peptide that contains the amino acid that is modified; and 3. Limitations of current LC-MS-MS acquisition and/or analysis techniques.
All limitations indicate crucial aspects where substantial technological improvement is needed.
Traditional discovery workflows using LC-MS-MS require prior knowledge of the mass of the modification and variable modification searches. This approach has three principal limitations:
1. Multiple modification searches exponentially increase data analysis times, limiting most searches to a few known modifications; 2. Identification is ultimately dependent on the modified peptide being sampled by data-dependent acquisition, a process known to be semi-stochastic and biased towards the identification of abundant species [20] ; and 3. These workflows only identify known protein modifications that are included as variable modifications in the database search. This may be the most important limitation because it biases identification and impedes discovery of novel modifications.
Other methods in proteomics include the growing field of targeted proteomics [21, 22] , but this technique also requires prior knowledge of the elemental composition of the modification such that appropriate precursor-fragment transitions can be chosen.
Data-independent acquisition (DIA) [23] coupled to targeted data extraction [24, 25] has offered an alternative workflow for analysis of proteomic samples using LC-MS-MS. DIA methods are based on fragment scans of wide isolation windows but can vary from 2 to >100m/z [23, [25] [26] [27] [28] . Although conventional data-dependent-acquisition strategies are extremely powerful for surveying proteomes [2] , methods based on independent acquisition offer specific benefits. The principal advantages are: improved reproducibility of peptide identifications, caused by the sequential scanning of isolation windows; potential improvements in quantitative accuracy, caused by improvements in signal-to-noise of MS2 versus MS1-based label-free quantitation; and, when coupled to targeted data extraction, the capability to re-query a dataset for any peptide of interest. Essentially, one can propose questions and test hypotheses in the data.
Herein, we describe an LC-MS-MS method named multiplex adduct peptide profiling (MAPP) to profile protein modifications without prior knowledge of the modification. The method consists of three steps, in which putative signals of interest are identified using the extraction of a fragment-ion tag, the mass of the modification is calculated by matching the fragment-ion tag to the appropriate precursor in retention-time space, and the mass of the modification is verified. The method relies on protein enrichment and targeted data extraction [24, 25] coupled to data-independent acquisition [23] . It can be used to investigate site-specific heterogeneity of targeted peptides of interest when the modification may be unknown. We discuss the development of the method, including limitations, and establish its potential to profile global adducts of two high-abundance proteins (serum albumin and hemoglobin) resulting from covalent modifications by reactive electrophiles in biological fluids. Reactive electrophiles are believed to be a major contributor to complex human diseases because they directly modify biopolymers [19, 29] . Reactive electrophiles are a substantial part of an individual's exposome [30] ; this is the totality of all exposures from conception onward, and is an emerging subject in disease research as a result of continued studies that suggest primary genetic factors often do not explain a majority of complex human disease risk [31] .
Methods

Materials
Formic acid (FA), ammonium bicarbonate (AB), hydrochloric acid (HCl), iodoacetamide (IAM), dithiothreitol (DTT), and sodium deoxycholate (SDC) were obtained from Sigma-Aldrich (St. Louis, MO). Trypsin was obtained from Promega (Madison, WI). HPLC-grade acetonitrile, methanol, and water were from Burdick & Jackson (Muskegon, MI). The hemoglobin peptide (GTFATLSELHCDK) was synthesized by and purchased from Thermo Fisher Scientific GmbH (Ulm, Germany). Combined plasma and blood obtained from smokers was purchased from BioreclamationIVT (New York, New York).
NanoLC MS-MS
The sample (2 μL) was injected onto an in-house-made 4 cm trap using an Easy nanoLC 1000 coupled to a Q Exactive Plus mass spectrometer (Bremen Germany). PicoFrit columns from New Objective (Woburn, MA) were packed to 25 cm in-house with 3 μm C18 silica particles (Dr. Maisch, Entringen, Germany). Mobile phase B was 99.9 % acetonitrile with 0.1 % formic acid, and mobile phase A was 98 % water, 2 % acetonitrile, and 0.1 % formic acid. A 90 min LC-MS-MS method was used and consisted of a linear gradient from 0-40 % B over 70 min, followed by a ramp to 80 % B in 1 min. The column was washed at 80 % B for 9 min and regenerated at 0 % B for 10 min.
Albumin and hemoglobin isolation and enrichment
Albumin isolation and adduct enrichment were performed based on the method described elsewhere [32] . In brief, ammonium sulfate was added to 4 mL plasma to create a 60 % saturated solution. Albumin was acid precipitated using HCl from the supernatant. Isolated albumin (500 μg) was added to 75 mg dry activated thiol sepharose in a spin column, and the flow-through fraction (nonmercaptoalbumin) was collected after 18 h enrichment. The enriched albumin fraction was then prepared using the filter-aided sample-preparation procedure for shotgun proteomics [7] . Samples were digested for 4 h at a trypsin-to-substrate ratio of 1:50. Hemoglobin and albumin sample preparation, including isolation, enrichment, and digestion, are described in detail in the supplemental materials.
DIA methods were created in Skyline [33] . The 21-aminoacid tryptic peptide from human serum albumin that contained the free Cys 3 4 residue was entered into Skyline (K.ALVLIAFAQYLQQCPFEDHVK.L). An isolation list was created in Skyline that used 12 10m/z isolation windows, which spanned m/z 810 to 930 but still contained the triply charged unmodified peptide precursor (m/z 811.7594). This range of precursor detection included the mass of the albumin-free, cysteine-unadducted peptide to a mass addition (i.e., adduct) of 360 Da, which encompasses the masses of all reported protein adducts except satratoxin G [19] . A similar procedure was used for the development of the method to monitor the tryptic peptide from the beta chain of hemoglobin that contained the free cysteine (GTFATLSELHCDK).
The isolation list was imported into the method editor of the Q Exactive Plus, and an MS1 scan was added every 12th scan from m/z 550 to 1300 for a maximum duty cycle of less than 1.5 s. For the MS1 scan the resolving power was set to 70,000 at m/z 200, and an automatic gain control (AGC) of 1e6 and a max injection time of 50 ms were used. For the DIA scans, the settings were: AGC of 1e6, 30 eV normalized collision energy (NCE), max injection time of 50 ms, and a resolving power of 17,500 at m/z 200.
Data analysis
In Skyline, precursors of increasing mass were created by adding artificial modifications to the Cys 34 or Cys 93 of the targeted albumin peptide or hemoglobin peptide, respectively. This step was performed so that Skyline extracted only the common fragment ions of the adducted peptide within each isolation window. Putative signals of interest (SOI) were identified by extracting common fragment ions from the Cys 34 -adducted peptides and finding the instances in retention-time space where all co-eluted with high mass-measurement accuracy (<5 ppm). In addition, the proportion of relative abundances of each fragment to total abundance was used to eliminate false positives. Once an SOI was identified, precursors were filtered on the basis of the isolation window from which the SOI originated and matched in retention-time space with the SOI using Xcalibur 2.2. This matching was based on the principle that, because the MS1 precursor and associated fragment ions all belong to the same chemical species, the chromatographic profile of each should be theoretically identical.
Unique ion signature SRM Collider [34] was used to further investigate the uniqueness of the common detected fragment ions (i.e., the signal of interest). This tool was originally developed for selectedreaction-monitoring experiments, but can be used to assess the uniqueness of coelution of fragment ions in dataindependent-acquisition experiments with the appropriate settings. The settings used were: Q1 mass window was set to 10m/ z (i.e. width of isolation window), Q3 mass window was set to 0.05m/z, m/z range 300-1500, three isotopes to consider, no missed cleavages, and the consideration of both b and y-type fragment ions from the human tryptic database. Transitions that were routinely detected were y 3 -y 7 and b 3 -b 6 for HSA Cys 34 peptide. For the hemoglobin Cys 93 peptide, b 4 -b 10 were detected. Using these settings, the detection and coelution of any combination of at least four of these fragment ions results in a unique ion signature (UIS) specific to the peptide of interest. Figure 1 displays the overall workflow for peptide-adduct studies by data-independent-acquisition mass spectrometry using a targeted data analysis. The method consists of a onedimensional reversed-phase liquid-chromatography separation followed by data-independent acquisition with a dedicated MS1 full scan (Fig. 1a) . Relatively wide isolation windows (m/z=10) at fixed incremental m/z increases are used to detect signals of interest (SOI). Data analysis and interpretation then follows a three-step process. In the first step a fragment-ion tag is extracted from the data, consisting of the b-type ion series and y-type ion series from the respective termini to the amino acid that is believed to be modified. Because this fragment-ion tag does not contain the amino acid that is potentially modified, all modified peptides will have this ion signature. It is important to note that this step assumes that all peptide adducts will behave in a similar way upon collision-induced dissociation. The point in retention time at which these fragment ions co-elute in the chromatogram is a signal of interest. In step 2, MS1 signals are overlaid with the signal of interest to match the precursor with corresponding fragment ions. The ambiguity in the correct MS1 feature is greatly reduced by only considering the precursors resulting from the isolation window at which the signals of interest (i.e., fragment ions) were generated. The degree of this complexity reduction is inversely proportional to the width of the isolation window. In addition, the assumption that an adducted peptide would have the same charge state as and a greater m/z than the unmodified peptide excludes many MS1 features. Next, on the basis of retention-time apex and peak shape, a putative precursor m/z representing the modified peptide can be identified. The signal can be further confirmed if the M, M+1, and M+2 precursor ions are extracted. Then the mass of the modification can be calculated using Eq. 1.
Results and discussion
Finally, in step 3 the mass of the modification can be verified by extracting the fragment ions that contain the modification calculated from step 2. If the mass is identified correctly, then coelution of additional adducted fragment ions should be observed. It is important to note that this step assumes that the modification is stable upon collision-induced dissociation, which will not be the case in all instances. Figure 1b summarizes the overall workflow using the tryptic peptide which contains a free cysteine (Cys 93 ) from the beta chain of hemoglobin that has been carbamidomethylated.
This procedure is a powerful strategy to both determine the number of putative modifications of a targeted peptide in complex mixtures or enriched samples and identify those modifications through accurate mass analysis. In theory each modification changes the hydrophobicity of the peptide, which then can be separated in time by reversed-phase chromatography. By counting the number of different peaks resulting from coelution of the unmodified fragment ions (i.e., signal of interest) one can determine the putative number of peptide adducts. Comparison of the relative abundance of each SOI reveals a similar ion-fragmentation signature. The b 3 and y 7 ions were found to be usually most abundant Fig. 1 An overview of the method used for multiplex adduct peptide profiling (MAPP). The scan cycle consists of a full MS1 scan followed by DIA scans. Data analysis consists of three steps for the identification of global peptide modifications.
Step 1 identifies potential signals of interest (SOI) by extracting the masses of unmodified fragment ions (i.e., tag).
Step 2 calculates the mass of the modification by matching co-eluting MS1 features to the fragment-ion tag extracted in step 1.
Step 3 verifies the calculation in step 2 by extracting the modified fragment ions. An alkylated tryptic peptide from the beta chain of hemoglobin was used to illustrate the workflow Figure 2 displays data from the LC-MS-MS analysis of human plasma after enrichment of modified mercaptoalbumin (Cys 34 ) using the method described with an isolation window of 10m/z. Human serum albumin and the tryptic peptide containing Cys 34 have been used for detecting peptide adducts in biological fluids [35] [36] [37] , including those related to smoking [38] . The width of the isolation window is an important variable, because large isolation windows decrease the sensitivity of peptide-adduct detection in complex mixtures (Electronic Supplementary Material (ESM) Fig. S1 ) by MAPP but inherently enable a larger m/z space to be investigated in a single run. First, unmodified fragment ions were extracted; three of the isolation windows are shown. Several signals of interest were observed, as identified by coelution and accurate mass (<5 ppm) of the unmodified fragment ions. Most of the adducts had little effect on retention time using our standard 90 min run, and eluted in the range 65-76 min. The ratio of the unmodified fragment ions can be used to help ensure positive identification of a putative peptide adduct and limit false positives. All 10 putative peptide adducts observed from these isolation windows had similar relative fragment-ion abundances, as illustrated in Fig. 2b . The most abundant fragment ion was the b 3 ion, followed by the y 7 ion. Interestingly, the Cys 34 tryptic peptide contains a proline amino acid (y 7 ), which is known to preferentially fragment (N-terminal) upon collisioninduced dissociation [39, 40] .
It is important to note at this point in the data analysis procedure that we have identified the number of potentially modified forms of a single peptide, a feat that is difficult to perform using current technology. However, we add to these new capabilities by matching the monoisotopic mass of the precursor ion to the SOI in retention-time space. Figure 3 displays this process for SOI #5. The retention time of interest is obtained from the tag (SOI #5=68.5 min). Then the full MS1 mass spectrum is inspected at that particular retention time. One can gain further specificity by only considering the MS1 features in the m/z range from the isolation window that created SOI #5 (Fig. 3b) . In this example, the m/z range was The full mass spectrum at 68.5 min is shown, which corresponded to SOI #5. The full scan can be further filtered to only show the precursors from the isolation window (inset) from which SOI #5 was generated (m/z 850-860). (c) A comparison between the elution profile of the putative precursor and SOI can be used to provide confidence in the match. The y axis was normalized to the maximum intensity of the summed fragment ions for SOI #5 and the extracted monoisotopic mass to assess similarity in elution profiles. SOI #5 was found to match the precursor 851.4261 in retention-time space Adducted fragment ions were then extracted from the data to verify this assignment of cysteine adduction. This step is heavily dependent on the stability of the modification upon collision-induced dissociation and on the abundance of the peptide adduct not complicated and the precursor m/z that resulted in SOI #5 was readily determined to be 851.4266 and verified by investigating the elution profiles of the tag (SOI #5) and precursor (Fig. 3c) . It is important to note that the efficacy of this step is heavily dependent on sample complexity, isolation-window width, and peak capacity. More robust tools and statistics are needed to provide confidence in the match between the elution profiles of the MS1 and signal of interest. Once the precursor m/z is accurately determined, an exact mass of the adduct can then be calculated using Eq. 1. For SOI #5, the mass of the modification was calculated to be 119.004 Da. On searching the literature, it was discovered that this mass is a common albumin adduct in biological fluids in which a thiol bond is created between two cysteine residues, which is known as cysteinylation. The verification step adds this mass to the Cys 34 residue and then overlays the modified fragment ions (Fig. 4) . Coelution of multiple fragment ions extracted with the elucidated mass provides confirmation of the belief that the peptide is adducted with the mass calculated. It is important to note that this final step will not be possible for some modifications and is dependent on the stability of the modification upon collisioninduced dissociation. In addition, the fragmentation efficiency and overall abundance of the peptide adduct will have an effect. Interestingly, increased human serum albumin Cys 34 cysteinylation has been revealed to be a marker for oxidative-stress-related diseases including diabetes mellitus and chronic liver and kidney diseases [41] .
Thirty-six signals of interest were observed, which represent putative adducts of Cys 34 albumin tryptic peptide, using coelution of fragment ions and accurate mass analysis across the 12 isolation windows. A list of identified peptide adducts is given in Table 1 . Several of these identified adducts have been reported elsewhere [42] . The list consists of different degrees of cysteine oxidation, including sulfenic (SOH), sulfinic (SO 2 H), and sulfonic acids (SO 3 H). Di and tri-oxidation were most prevalent. Several SOIs could not be identified because of the lack of resources (i.e. databases) available for known peptide adducts and software to streamline the data mining. Also, it is worth noting that some of these SOIs probably result from in-vitro modifications (i.e., sample handling and/or storage) to the cysteine, modifications of other residues (e.g. Gln), or a with the modification determined to be 170.1208 Da. We found there to be interference in some of the modified fragment ions upon extraction combination of both. With improved software and extraction methods, pinpointing the site of modification could be performed using the common and modified fragment ions, as used elsewhere to assign sites of methionine oxidation [24] . Regardless, MAPP is a powerful strategy to discover and profile targeted-peptide modifications in proteomic samples. In theory, MAPP can be used to investigate modifications of any targeted peptide(s) of interest. To provide another example, we isolated hemoglobin from blood (see Supplemental Section) and analyzed the peptide that contains the free cysteine (GTFATLSELHCDK) from the beta chain of hemoglobin. All b-type fragment ions from the N-terminus up to the free cysteine (Cys 93 ) were extracted (b 4 -b 10 ). Because this amino acid of interest was near the C-terminus of the tryptic peptide, we did not extract any of the y fragment ions. Similarly to the albumin study, both di and tri oxidation forms were readily observed (ESM , Table S1 ). However, Fig. 5 reveals the power of MAPP to detect unexpected and/or unknown modifications that would probably have never been detected by traditional database approaches. In this example, the modification was elucidated using MAPP to have a mass of 170.1208 Da, but could not be readily identified on the basis of previous reports and available databases. To confirm positive detection of hemoglobin Cys 93 adducts, the sample was analyzed by a traditional data-dependent acquisition workflow using the quadrupole Orbitrap. The raw data was searched using a variable modification search which included cysteine oxidation and the mass of the unknown modification (170.1208 Da). Spectra matching all three hemoglobin cysteine adducts were identified by DDA with high confidence (posterior error probability<0.01) [43] .
Future applications will use MAPP to investigate the adductome in relation to diseases with environmental causes. In addition, we will investigate the ability to provide an adduct fingerprint in efforts to classify exposure to complex substances (cigarette smoke, air pollution, etc.) from human epidemiological studies. Work is ongoing to develop normalization procedures for peptide-adduct quantitation, more objective metrics and/or statistics for identification, and automated workflows for matching MS1 to unique ion signatures (UIS).
Conclusions
A novel method termed multiplex adduct peptide profiling (MAPP), which provides a framework to investigate multiple modifications of a single amino acid along a peptide backbone, was developed. The authors note that, although the initial application has focused on adductomics, the method could be applied to other in-vivo modifications (e.g. protein glycosylation heterogeneity) if the protein of interest could be efficiently isolated and enriched. Enrichment is typically crucial in these experiments, because in-vivo modifications occur at sub-stoichiometric levels. As with any method, some limitations exist. The specificity of the tag (i.e., SOI) may restrict the method's use for small peptides in complex mixtures. Performed as described above, tag specificity can be evaluated by using the SRM collider [34] to determine if the tag represents a unique ion signature within the precursor isolation windows of interest and organism under study. In addition, it is important to consider the complexity of the precursor isolation window, which is dependent on the separation efficiency (i.e., peak capacity), sample complexity, and the width of the isolation window, because it will affect the efficacy of matching the correct MS1 feature to the fragment-ion tag of interest. More advanced DIA techniques that improve precursor specificity by isolating nonadjacent windows could be used [25] .
